Literature DB >> 24120917

Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis.

Eun Jeong Lee1, Un-Jung Yun, Kyung Hee Koo, Jee Young Sung, Jaegal Shim, Sang-Kyu Ye, Kyeong-Man Hong, Yong-Nyun Kim.   

Abstract

Lipid rafts, plasma membrane microdomains, are important for cell survival signaling and cholesterol is a critical lipid component for lipid raft integrity and function. DHA is known to have poor affinity for cholesterol and it influences lipid rafts. Here, we investigated a mechanism underlying the anti-cancer effects of DHA using a human breast cancer cell line, MDA-MB-231. We found that DHA decreased cell surface levels of lipid rafts via their internalization, which was partially reversed by cholesterol addition. With DHA treatment, caveolin-1, a marker for rafts, and EGFR were colocalized with LAMP-1, a lysosomal marker, in a cholesterol-dependent manner, indicating that DHA induces raft fusion with lysosomes. DHA not only displaced several raft-associated onco-proteins, including EGFR, Hsp90, Akt, and Src, from the rafts but also decreased total levels of those proteins via multiple pathways, including the proteasomal and lysosomal pathways, thereby decreasing their activities. Hsp90 overexpression maintained its client proteins, EGFR and Akt, and attenuated DHA-induced cell death. In addition, overexpression of Akt or constitutively active Akt attenuated DHA-induced apoptosis. All these data indicate that the anti-proliferative effect of DHA is mediated by targeting of lipid rafts via decreasing cell surface lipid rafts by their internalization, thereby decreasing raft-associated onco-proteins via proteasomal and lysosomal pathways and decreasing Hsp90 chaperone function.
© 2013.

Entities:  

Keywords:  Akt; Cholesterol; Docosahexaenoic acid (DHA); EGFR; Hsp90; Lipid raft

Mesh:

Substances:

Year:  2013        PMID: 24120917     DOI: 10.1016/j.bbalip.2013.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.

Authors:  Carol J Fabian; Bruce F Kimler; Teresa A Phillips; Jennifer L Nydegger; Amy L Kreutzjans; Susan E Carlson; Brandon H Hidaka; Trina Metheny; Carola M Zalles; Gordon B Mills; Kandy R Powers; Debra K Sullivan; Brian K Petroff; Whitney L Hensing; Brooke L Fridley; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

2.  NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.

Authors:  Guangbi Li; Zhida Chen; Owais M Bhat; Qinghua Zhang; Justine M Abais-Battad; Sabena M Conley; Joseph K Ritter; Pin-Lan Li
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

3.  Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression In Vivo.

Authors:  L Allyson Checkley; Michael C Rudolph; Elizabeth A Wellberg; Erin D Giles; Reema S Wahdan-Alaswad; Julie A Houck; Susan M Edgerton; Ann D Thor; Pepper Schedin; Steven M Anderson; Paul S MacLean
Journal:  Cancer Prev Res (Phila)       Date:  2017-02-02

4.  Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women.

Authors:  Carol J Fabian; Bruce F Kimler; Teresa A Phillips; Jessica A Box; Amy L Kreutzjans; Susan E Carlson; Brandon H Hidaka; Trina Metheny; Carola M Zalles; Gordon B Mills; Kandy R Powers; Debra K Sullivan; Brian K Petroff; Whitney L Hensing; Brooke L Fridley; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2015-10

5.  Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy.

Authors:  Yin Shi; Shi-Hao Tan; Shukie Ng; Jing Zhou; Na-Di Yang; Gi-Bang Koo; Kerrie-Ann McMahon; Robert G Parton; Michelle M Hill; Miguel A Del Pozo; You-Sun Kim; Han-Ming Shen
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

6.  N-3 vs. n-6 fatty acids differentially influence calcium signalling and adhesion of inflammatory activated monocytes: impact of lipid rafts.

Authors:  Martina Barbara Schaefer; Christian Alexander Schaefer; Stefanie Schifferings; Christoph Rüdiger Wolfram Kuhlmann; Annett Urban; Utz Benscheid; Tobias Fischer; Matthias Hecker; Rory E Morty; Istvan Vadasz; Susanne Herold; Martin Witzenrath; Werner Seeger; Ali Erdogan; Konstantin Mayer
Journal:  Inflamm Res       Date:  2016-07-06       Impact factor: 4.575

7.  Statin derivatives as therapeutic agents for castration-resistant prostate cancer.

Authors:  Matthew A Ingersoll; Dannah R Miller; October Martinez; C Brent Wakefield; Kuan-Chan Hsieh; M Vijaya Simha; Chai-Lin Kao; Hui-Ting Chen; Surinder K Batra; Ming-Fong Lin
Journal:  Cancer Lett       Date:  2016-09-26       Impact factor: 8.679

8.  Azurin interaction with the lipid raft components ganglioside GM-1 and caveolin-1 increases membrane fluidity and sensitivity to anti-cancer drugs.

Authors:  Nuno Bernardes; Ana Rita Garizo; Sandra N Pinto; Bernardo Caniço; Catarina Perdigão; Fábio Fernandes; Arsenio M Fialho
Journal:  Cell Cycle       Date:  2018-08-04       Impact factor: 4.534

Review 9.  Omega-3 fatty acids for breast cancer prevention and survivorship.

Authors:  Carol J Fabian; Bruce F Kimler; Stephen D Hursting
Journal:  Breast Cancer Res       Date:  2015-05-04       Impact factor: 6.466

10.  α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways.

Authors:  Julie K Mason; Sukhpreet Klaire; Shikhil Kharotia; Ashleigh K A Wiggins; Lilian U Thompson
Journal:  Lipids Health Dis       Date:  2015-08-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.